Value of Von Willebrand Factor as a Predictor for Osteoporosis Development in Women with Hypothyroidism

Main Article Content

I.V. Pankiv


The paper presents the study of the value of von Willebrand factor as a marker of endothelial dysfunction for osteoporosis development and for prediction of risk of its formation in women with hypothyroidism. Postmenopausal women with hypothyroidism have significant increase of von Willebrand factor at lumbar osteopenia. High concentrations of von Willebrand factor in women with hypothyroidism follows to consider it as a predictor for osteoporosis development. Increased level of С-reactive protein belongs to the unfavorable prognostic signs in relation to the decline of bone mineral density for patients with primary hypothyroidism.

Article Details

How to Cite
Pankiv, I. “Value of Von Willebrand Factor As a Predictor for Osteoporosis Development in Women With Hypothyroidism”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), no. 5.69, Nov. 2015, pp. 125-9, doi:10.22141/2224-0721.5.69.2015.75195.
Clinical Thyroidology


Dhanwal D.K., Dennison E.M., Harvey N.C., Cooper C. Epidemiology of hip fracture: Worldwide geographic variation // Indian J. Orthop. — 2011. — Vol. 45(1). — P. 15-22. doi: 10.4103/0019-5413.73656.

Sattui S.E., Saag K.G. Fracture mortality: associations with epidemiology and osteoporosis treatment // Nat. Rev. Endocrinol. — 2014. — Vol. 10(10). — P. 592-602. doi: 10.1038/nrendo.2014.125.

Cangoz S., Chang Y.Y., Chempakaseril S.J. et al. Vitamin D and type 2 diabetes mellitus // J. Clin. Pharm. Ther. — 2013. — Vol. 38. — P. 81-84.

Souberbielle J.-C., Body J.-J., Lappe J.M. et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice // Autoimmunity Reviews. — 2010. — Vol. 9(11). — P. 709-715.

Garin M.C., Arnold A.M., Lee J.S. et al. Subclinical thyroid dysfunction and hip fracture and bone mineral density in older adults: the cardiovascular health study // J. Clin. Endocrinol. Metab. — 2014. — Vol. 99(8). — P. 2657-2664. doi: 10.1210/jc.2014-1051.

Марова Е.И., Ахкунбекова Н.К., Рожинская Л.Я. и др. Кальций-фосфорный обмен и костный метаболизм у больных с первичным гипотиреозом // Остеопороз и остеопатии. — 2000. — № 3. — С. 13-16.

Ночевная Л.Б., Павленко О.А., Килина О.Ю., Столярова В.А. Состояние костной ткани у больных с впервые выявленным гипотиреозом // Сибирский медицинский журнал. — 2011. — Т. 26, № 4. — С. 189-192.

Amashukeli M., Giorgadze E., Tsagareli M. et al. The impact of thyroid diseases on bone metabolism and fracture risk // Georgian Med. News. — 2010. — № 184–185. — P. 34-39.

Sadler J.E. Low von Willebrand factor: sometimes a risk factor and sometimes a disease / J.E. Sadler // Hematology Am. Soc. Hematol. Educ. Program. — 2009. — Vol. 106–12. doi: 10.1182/asheducation-2009.1.106.

Fan W., Bouwense S.A., Crawford R., Xiao Y.J. Structural and cellular features in metaphyseal and diaphyseal periosteum of osteoporotic rats // Mol. Histol. — 2010. — Vol. 41(1). — P. 51-60. doi: 10.1007/s10735-010-9261-y.

Most read articles by the same author(s)

1 2 3 4 > >>